Trade ARGX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
argenx SE American Depositary Shares (ARGX) is trading at US$990.32, down 0.55% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$65.05B. Over the past 52 weeks, ARGX has traded between US$661.85 and US$1,072.75. On Syfe you can trade ARGX with $0 commission and add it to your watchlist.
| Previous close | US$995.77 |
|---|---|
| Market cap | US$65.05B |
| P/E ratio | 27.68 |
| 52-week range | US$661.85 – US$1,072.75 |
| Volume | 243.31K |
| Exchange | US |
Add to Watchlist
Set Price Alert
argenx SE American Depositary Shares
argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Year: 2017
Argenx's Myositis Data Derisk Vyvgart Opportunity, Oppenheimer Says
Aug 18, 3:35 PM · MT Newswires
Argenx's Vyvgart Hytrulo Likely to Get FDA Approval for Myositis, RBC Says
Aug 18, 3:06 PM · MT Newswires
Argenx's Myositis Data Strengthen Efgartigimod Outlook, Morgan Stanley Says
Aug 18, 2:54 PM · MT Newswires
Oppenheimer Adjusts Price Target on argenx to $1,100 From $1,037, Maintains Outperform Rating
Aug 18, 12:44 PM · MT Newswires
Stay on top of ARGX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
